Noopur Singh, Xentria

Noopur’s motivation stems from her desire to help mitigate treatment access challenges seen across indications. She is focused on strategic patient-centered drug development that bridges scientific gaps and cuts through red tape across the drug supply chain. Her approach stems from the patient journey, ensuring it is integrated throughout the drug development life cycle.

In her role at Xentria, Noopur nurtures Xentria’s key relationships with patient experts, key opinion leaders and clinical investigators while leading business development and partnering strategy. Working in collaboration with cross-functional teams on strategy and research & development efforts, she leads medical affairs initiatives, including publications, conferences, and clinical education programs.

Prior to her role at Xentria, Noopur was the Research Director at the Foundation for Sarcoidosis Research where she played a key role in the development and execution of the organization’s scientific research agenda.